IPI urges the Trump administration to forbear importing the price controls of socialist health care systems to the U.S.
The United States is on the verge of reaching energy independence, a goal that Congress has sought for more than four decades, according to a new paper from the Institute for Policy Innovation.
IPI commends the FCC for today’s announcement, and urges prompt movement toward a successful public auction for C-band spectrum.
The DC Circuit Court of Appeals has validated the FCC's ‘Restoring Internet Freedom Order,’ which restores the longtime ‘light touch’ regulatory approach to the internet.
House Speaker Nancy Pelosi’s drug pricing scheme slaps government price controls on Medicare Parts B and D, financially punishes any drug manufacturer that cannot accept the government-imposed price, and puts Washington’s financial interests before the well-being of actual patients.
A new IPI publication says the revived effort to legalize the importation of prescription drugs has bipartisan support, but the practice remains just as dangerous as ever, since the lawmakers who hope to benefit from the scheme’s political expediency simply cannot guarantee the safety of imported drugs.
NASA Administrator Jim Bridenstine will visit Dallas on Friday, September 13, to highlight NASA’s mission to return to the Moon and enable human exploration of Mars in keynote remarks before the Institute for Policy Innovation’s Sumners Distinguished Lecture Series.
We appreciate the FCC’s aggressive efforts to protect consumer interests and ensure that out-of-control local governments don’t erect counterproductive barriers to increased adoption of broadband services throughout the country.
A new Health and Human Services rule requiring pharmaceutical companies to disclose list prices for medications in commercial advertisements is unlikely to boost price transparency for consumers. In fact, it may create even more confusion.